Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial
Author:
Adriano Lazzarin,Thomas Campbell,Bonaventura Clotet,Margaret Johnson,Christine Katlama,Arend Moll,William Towner,Benoit Trottier,Monika Peeters,Johan Vingerhoets,Goedele de Smedt,Benny Baeten,Greet Beets,Rekha Sinha,Brian Woodfall
Copyright © 2007 Elsevier Ltd. All rights reserved.